News &
Updates

WHO PQS

Press ReleaseRevital Healthcare EPZ Ltd. Achieves WHO...

Revital banks blanket contract from a key global organisation

Revital Healthcare has been contracted by a global organization to supply 50 million pieces of the 2ml vaccine syringes as the world braces for a shortage of the commodity. Revital won the tender worth Sh150 million after a competitive bid with other leading manufacturers. Because of this shortage of various types of Syringes Revital Healthcare shall also supply the 0.5ML Auto-Disable Syringe globally, as organisations seek for an alternative solution for syringes which could be used for vaccination.

Revital becomes sole company in African to manufacture Covid-19 vaccine syringes

Revital has put the country on the global map in the fight against Covid-19 after it became the only company in Africa licensed to produce Covid-19 vaccine syringes. Revital Healthcare (EPZ) Limited is one of only six firms in the world approved by the World Health Organization to produce the specialized syringes. On Thursday, Nigeria became the first country to receive the auto-disable syringes.

STAY UP
TO DATE

Revital banks blanket contract from a key global organisation

Revital banks blanket contract from a key global organisation

Revital Healthcare has been contracted by a global organization to supply 50 million pieces of the 2ml vaccine syringes as the world braces for a shortage of the commodity. Revital won the tender worth Sh150 million after a competitive bid with other leading manufacturers. Because of this shortage of various types of Syringes Revital Healthcare shall also supply the 0.5ML Auto-Disable Syringe globally, as organisations seek for an alternative solution for syringes which could be used for vaccination.